Division of Nephrology, Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Data Science Center, Jichi Medical University, Tochigi, Japan.
PLoS One. 2021 Oct 21;16(10):e0259064. doi: 10.1371/journal.pone.0259064. eCollection 2021.
The hepato-splanchnic circulation directly influences oxygenation of the abdominal organs and plays an important role in compensating for the blood volume reduction that occurs in the central circulation during hemodialysis (HD) with ultrafiltration. However, the hepato-splanchnic circulation and oxygenation cannot be easily evaluated in the clinical setting of HD therapy. We included 185 HD patients and 15 healthy volunteers as the control group in this study. Before HD, hepatic regional oxygen saturation (rSO2), a marker of hepatic oxygenation reflecting the hepato-splanchnic circulation and oxygenation, was monitored using an INVOS 5100c oxygen saturation monitor. Hepatic rSO2 was significantly lower in patients undergoing HD than in healthy controls (56.4 ± 14.9% vs. 76.2 ± 9.6%, p < 0.001). Multivariable regression analysis showed that hepatic rSO2 was independently associated with body mass index (BMI; standardized coefficient: 0.294), hemoglobin (Hb) level (standardized coefficient: 0.294), a history of cardiovascular disease (standardized coefficient: -0.157), mean blood pressure (BP; standardized coefficient: 0.154), and serum albumin concentration (standardized coefficient: 0.150) in Model 1 via a simple linear regression analysis. In Model 2 using the colloid osmotic pressure (COP) in place of serum albumin concentration, the COP (standardized coefficient: 0.134) was also identified as affecting hepatic rSO2. Basal hepatic oxygenation before HD might be affected by BMI, Hb levels, a history of cardiovascular disease, mean BP, serum albumin concentration, and the COP. Further prospective studies are needed to clarify whether changes in these parameters, including during HD, affect the hepato-splanchnic circulation and oxygenation in HD patients.
肝脾循环直接影响腹部器官的氧合作用,并在血液透析(HD)超滤过程中中心循环血容量减少时发挥重要的代偿作用。然而,在 HD 治疗的临床环境中,肝脾循环和氧合作用不易评估。我们纳入了 185 例 HD 患者和 15 例健康志愿者作为对照组。在 HD 之前,使用 INVOS 5100c 氧饱和度监测仪监测肝区域性氧饱和度(rSO2),这是反映肝脾循环和氧合作用的肝氧合标志物。接受 HD 的患者的肝 rSO2 明显低于健康对照组(56.4 ± 14.9% vs. 76.2 ± 9.6%,p < 0.001)。多变量回归分析显示,肝 rSO2 与体重指数(BMI;标准化系数:0.294)、血红蛋白(Hb)水平(标准化系数:0.294)、心血管疾病史(标准化系数:-0.157)、平均血压(BP;标准化系数:0.154)和血清白蛋白浓度(标准化系数:0.150)在模型 1 中独立相关,通过简单线性回归分析。在使用胶体渗透压(COP)替代血清白蛋白浓度的模型 2 中,COP(标准化系数:0.134)也被确定为影响肝 rSO2 的因素。HD 前的基础肝氧合可能受 BMI、Hb 水平、心血管疾病史、平均 BP、血清白蛋白浓度和 COP 的影响。需要进一步的前瞻性研究来阐明这些参数的变化,包括在 HD 过程中的变化,是否会影响 HD 患者的肝脾循环和氧合作用。